C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/04 (2006.01) C07D 413/04 (2006.01) C07D 417/04 (2006.01)
Patent
CA 2689117
The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein A, R1, R2, R3 and m, are defined in the description. The present invention relates also to methods of making said compounds, and compositions containing said compounds which are useful for inhibiting kinases such as Glycogen Synthase kinase 3 (GSK-3), Rho kinase (ROCK), Janus Kinases (JAK), AKT, PAK4, PLK, CK2, KDR, MK2, JNK1, aurora, pim 1 and nek 2.
L'invention concerne des composés de formule (I) ou des sels pharmaceutiquement acceptables, où A, R1, R2, R3 et m sont définis dans la description. L'invention concerne également des procédés de préparation desdits composés ainsi que des compositions contenant lesdits composés servant à inhiber les kinases telles que la glycogène synthase kinase 3 (GSK-3), la Rho kinase (ROCK), les Janus kinases (JAK), AKT, PAK4, PLK, CK2, KDR, MK2, JNK1, aurore, pim 1 et nek 2.
Akritopoulou-Zanze Irini
Bakker Margaretha
Djuric Stevan W.
Frank Kristine
Gasiecki Alan F.
Abbott Gmbh & Co. Kg
Abbott Laboratories
Akritopoulou-Zanze Irini
Bakker Margaretha
Djuric Stevan W.
LandOfFree
5-heteroaryl substituted indazoles as kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-heteroaryl substituted indazoles as kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-heteroaryl substituted indazoles as kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1901018